Sanara MedTech Inc. (NASDAQ:SMTI) Q2 2024 Earnings Conference Call August 13, 2024 9:00 AM ET

Company Participants

Callon Nichols - Vice President of Corporate Operations
Ronald Nixon - Executive Chairman and CEO
Michael McNeil - CFO and Corporate Secretary
Seth Yon - President of Commercial
Jacob Waldrop - Chief Operating Officer

Sam Muppalla - Tissue Health Plus

Conference Call Participants

Ross Osborn - Cantor Fitzgerald
Ian Cassel - MicroCapClub
John Siedhoff - Twin Oaks Equity LLC

Operator

Greetings, welcome to the Sanara MedTech Inc.'s Second Quarter Results and Business Updates. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.

I will now turn the conference over to your host, Callon Nichols, Director of Investor Relations at Sanara MedTech. Callon, you may begin.

Callon Nichols

Thank you and good morning, everyone. I'd like to welcome you to Sanara MedTech's earnings conference call for the quarter ended June 30, 2024. We issued our earnings release yesterday morning and I would like to highlight that we have posted today's deck on the investor relations page of our website. This supplemental deck, as well as a copy of the earnings release, and the Form 10-Q for the quarter ended June 30, 2024, are also available on this page. We will reference this information in our remarks today.

With us today are Ron Nixon, our Executive Chairman and CEO; Mike McNeil, our Chief Financial Officer; Seth Yon, our President of Commercial; Jake Waldrop, our Chief Operating Officer; and Sam Muppalla who leads Tissue Health Plus.

Please note that certain statements in this conference call and our press release and in our supplemental deck include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For more information about the risks and uncertainties involving forward-looking statements and factors that could cause actual results to differ materially from those projected or implied by forward-looking statements, please see the risk factor set forth in our most recent Annual Report on Form 10-K, as supplemented by the risk factors in our most recent quarterly report on Form 10-Q.

Also, this conference call, our earnings release and our supplemental deck reference certain non-GAAP measures. In that regard, I direct you to the reconciliation of these measures and the earnings materials that are available on our website.

Now I'd like to turn the call over to Ron.